东富龙(300171)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300171 东富龙

已收盘 10-08 15:00:00

{"stockData":{"symbol":"300171","market":"SZ","secType":"STK","nameCN":"东富龙","latestPrice":15.95,"timestamp":1791443031000,"preClose":16.43,"halted":0,"volume":25148131,"delay":0,"changeRate":-0.0292,"floatShares":569000000,"shares":766000000,"eps":0.3423,"marketStatus":"已收盘","change":-0.48,"latestTime":"10-08 15:00:00","open":16.51,"high":16.75,"low":15.82,"amount":404000000,"amplitude":0.0566,"askPrice":15.96,"askSize":5,"bidPrice":15.95,"bidSize":104,"shortable":0,"etf":0,"ttmEps":0.3423,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791509400000},"marketStatusCode":5,"adr":0,"adjPreClose":16.43,"symbolType":"stock","openAndCloseTimeList":[[1791423000000,1791430200000],[1791435600000,1791442800000]],"highLimit":18.07,"lowLimit":14.79,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":765828040,"isCdr":false,"pbRate":1.58,"roa":"--","peRate":46.596553,"roe":"1.35%","epsLYR":0.26,"committee":-0.045064,"marketValue":12215000000,"turnoverRate":0.0442,"status":1,"floatMarketCap":9068000000},"requestUrl":"/m/hq/s/300171","defaultTab":"news","newsList":[{"id":"2673053049","title":"东富龙（300171）9月30日主力资金净买入4016.52万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2673053049","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673053049?lang=zh_cn&edition=full","pubTime":"2026-10-08 09:06","pubTimestamp":1791421575,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月30日收盘，东富龙报收于16.43元，上涨3.33%，换手率4.07%，成交量23.17万手，成交额3.82亿元。近5日资金流向一览见下表：东富龙融资融券信息显示，融资方面，当日融资买入3120.01万元，融资偿还3701.36万元，融资净偿还581.35万元。融券方面，融券卖出2300.0股，融券偿还1.39万股，融券余量19.17万股，融券余额314.96万元。东富龙主营业务：制药装备的研发、生产、销售和技术服务等。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800002971.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300171"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669497438","title":"股市必读：东富龙（300171）9月23日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2669497438","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669497438?lang=zh_cn&edition=full","pubTime":"2026-09-24 01:36","pubTimestamp":1790184972,"startTime":"0","endTime":"0","summary":"截至2026年9月23日收盘，东富龙报收于16.32元，上涨3.23%，换手率4.58%，成交量26.02万手，成交额4.25亿元。董秘最新回复投资者： 美元升值，对公司国际化发展是大利好吗？当日关注点交易信息汇总：9月23日主力资金净流出808.13万元，占总成交额1.9%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400002093.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300171"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669061831","title":"东富龙：稳步推进海外市场拓展","url":"https://stock-news.laohu8.com/highlight/detail?id=2669061831","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669061831?lang=zh_cn&edition=full","pubTime":"2026-09-23 16:00","pubTimestamp":1790150454,"startTime":"0","endTime":"0","summary":"证券之星消息，东富龙(300171)09月23日在投资者关系平台上答复投资者关心的问题。投资者提问：美元升值，对公司国际化发展是大利好吗？东富龙回复：您好，公司及时关注汇率变动情况，积极采取措施有效应对和规避汇率变动可能带来的不利影响。目前公司正稳步推进海外市场拓展，在营销重点区域加强本土营销能力、项目管理能力、制造生产能力及售后服务能力的建设，推动公司国际化发展，致力于成为全球化药机头部企业。谢谢。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300024661.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300171"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669105209","title":"东富龙：坚持\"专业技术服务于生物医药\"","url":"https://stock-news.laohu8.com/highlight/detail?id=2669105209","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669105209?lang=zh_cn&edition=full","pubTime":"2026-09-23 15:42","pubTimestamp":1790149331,"startTime":"0","endTime":"0","summary":"证券之星消息，东富龙09月23日在投资者关系平台上答复投资者关心的问题。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300022240.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","399441","161726","300171"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668949089","title":"9月18日东富龙涨7.59%，金信深圳成长混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2668949089","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668949089?lang=zh_cn&edition=full","pubTime":"2026-09-18 16:46","pubTimestamp":1789721178,"startTime":"0","endTime":"0","summary":"证券之星消息，9月18日东富龙涨7.59%，收盘报15.45元，换手率5.83%，成交量33.15万手，成交额5.0亿元。重仓东富龙的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为金信基金的金信深圳成长混合A。金信深圳成长混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091800025952.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300171"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668946658","title":"东富龙：在制剂装备、生物工艺装备及耗材等领域进行战略布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2668946658","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668946658?lang=zh_cn&edition=full","pubTime":"2026-09-18 16:01","pubTimestamp":1789718460,"startTime":"0","endTime":"0","summary":"证券之星消息，东富龙09月18日在投资者关系平台上答复投资者关心的问题。谢谢东富龙回复：您好，公司在发展过程中洞察行业发展趋势及技术前沿，在制剂装备、生物工艺装备及耗材、制药工程、食品装备及工程等领域进行战略布局，相关产品也已在客户端广泛应用，具有市场竞争力。未来公司将持续推动多业务协同发展，加强公司整体增长空间。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091800022048.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300171"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667880559","title":"东富龙：9月16日召开业绩说明会，投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2667880559","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667880559?lang=zh_cn&edition=full","pubTime":"2026-09-16 20:02","pubTimestamp":1789560175,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年9月16日东富龙发布公告称公司于2026年9月16日召开业绩说明会。东富龙主营业务：制药装备的研发、生产、销售和技术服务等。融资融券数据显示该股近3个月融资净流出2157.6万，融资余额减少；融券净流入250.08万，融券余额增加。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091600033686.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300171","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667525693","title":"东富龙获得实用新型专利授权：“一种袋体回收装置”","url":"https://stock-news.laohu8.com/highlight/detail?id=2667525693","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667525693?lang=zh_cn&edition=full","pubTime":"2026-09-15 03:32","pubTimestamp":1789414330,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示东富龙新获得一项实用新型专利授权，专利名为“一种袋体回收装置”，专利申请号为CN202521834012.4，授权日为2026年9月15日。本实用新型的目的在于克服现有的缺陷而提供的一种袋体回收装置，简化了结构，降低了维护成本。今年以来东富龙新获得专利授权96个，较去年同期增加了47.69%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091500002428.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300171"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667659000","title":"9月14日东富龙涨8.09%，金信深圳成长混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2667659000","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667659000?lang=zh_cn&edition=full","pubTime":"2026-09-14 16:39","pubTimestamp":1789375198,"startTime":"0","endTime":"0","summary":"证券之星消息，9月14日东富龙涨8.09%，收盘报13.89元，换手率3.23%，成交量18.36万手，成交额2.49亿元。重仓东富龙的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为金信基金的金信深圳成长混合A。金信深圳成长混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400021185.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300171","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666411542","title":"东富龙：公司国际化战略布局效果显现","url":"https://stock-news.laohu8.com/highlight/detail?id=2666411542","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666411542?lang=zh_cn&edition=full","pubTime":"2026-09-11 16:18","pubTimestamp":1789114695,"startTime":"0","endTime":"0","summary":"证券之星消息，东富龙09月11日在投资者关系平台上答复投资者关心的问题。东富龙回复：你好，公司2026年半年度主要业绩驱动因素如下：公司国际化战略布局效果显现，国际营业收入持续增长，实现国际营业收入103,983.34万元，较上年同期增长29.24%。国内业务毛利企稳，运营效率提升。公司坚持国内国际双市场策略，继续夯实国内制药装备行业市场地位，积极拓展海外市场份额，争取以更好的业绩回馈投资者。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100034390.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300171"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666494542","title":"东富龙：致力于成为智慧药厂的交付者、全球化药机头部企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2666494542","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666494542?lang=zh_cn&edition=full","pubTime":"2026-09-11 16:18","pubTimestamp":1789114689,"startTime":"0","endTime":"0","summary":"证券之星消息，东富龙(300171)09月11日在投资者关系平台上答复投资者关心的问题。投资者提问：公司海外业务收入占比已经有了成效，但还没过半，希望公司能成为世界的东富龙！尽快开动两个募投项目，抢占先机！东富龙回复：感谢您的关注与建议！公司始终坚持国际化战略，积极投身全球制药产能基础建设，已有超10,000台制药设备、药品制造系统服务于全球50多个国家和地区的近3,000家全球知名制药企业，致力于成为智慧药厂的交付者、全球化药机头部企业。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100034377.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300171"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666597422","title":"股市必读：东富龙新发布《关于参加2026年上海辖区上市公司集体接待日暨中报业绩说明会活动的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2666597422","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666597422?lang=zh_cn&edition=full","pubTime":"2026-09-11 01:17","pubTimestamp":1789060629,"startTime":"0","endTime":"0","summary":"截至2026年9月10日收盘，东富龙报收于13.32元，下跌2.49%，换手率1.6%，成交量9.12万手，成交额1.22亿元。当日关注点交易信息汇总：9月10日主力资金净流出1252.36万元，占总成交额10.3%。公司公告汇总：东富龙将于2026年9月16日15:00–17:00通过“全景路演”平台举行中报业绩说明会，投资者可提前提交问题。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100002120.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300171","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664817100","title":"东富龙（300171）披露2026年半年度权益分派实施公告，9月2日股价下跌4.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664817100","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664817100?lang=zh_cn&edition=full","pubTime":"2026-09-02 22:22","pubTimestamp":1788358934,"startTime":"0","endTime":"0","summary":"截至2026年9月2日收盘，东富龙报收于14.38元，较前一交易日下跌4.32%，最新总市值为110.13亿元。该股当日开盘14.85元，最高14.95元，最低14.37元，成交额达2.17亿元，换手率为2.61%。近日，东富龙科技集团股份有限公司发布《2026年半年度权益分派实施公告》。股权登记日为2026年9月9日，除权除息日为2026年9月10日。现金红利由中国结算深圳分公司代派，部分股东由公司自行派发。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200042907.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300171","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664892537","title":"东富龙：专门从事洁净药厂建设工程服务","url":"https://stock-news.laohu8.com/highlight/detail?id=2664892537","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664892537?lang=zh_cn&edition=full","pubTime":"2026-09-02 16:01","pubTimestamp":1788336060,"startTime":"0","endTime":"0","summary":"证券之星消息，东富龙(300171)09月02日在投资者关系平台上答复投资者关心的问题。投资者提问：公司有半导体洁净室的技术吗？有这个业务吗？目前订单如何？东富龙回复：您好，公司旗下制药工程事业部，秉承专业技术服务于生物医药的使命，专门从事洁净药厂建设工程服务、洁净空调设备研发与生产、制药用水系统设备研发与生产。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200025724.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300171"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664132831","title":"东富龙：2026年半年度实现国际营业收入103,983.34万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2664132831","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664132831?lang=zh_cn&edition=full","pubTime":"2026-09-01 15:48","pubTimestamp":1788248891,"startTime":"0","endTime":"0","summary":"证券之星消息，东富龙09月01日在投资者关系平台上答复投资者关心的问题。公司2026年半年度实现国际营业收入103,983.34万元，较上年同期增长 29.24%。公司坚持国内国际双市场驱动的战略，依靠国际化战略布局，公司积极开拓国际市场，通过交付标杆项目提升国际品牌知名度，逐步建立国际客户圈层及信任度，进一步提升国际业务收入。公司将持续关注市场环境变化情况，加强对募投项目建设进度的管理和监督，推动项目的有序实施。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100023619.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300171"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662906642","title":"东富龙(300171)6月30日股东户数2.93万户，较上期减少2.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662906642","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662906642?lang=zh_cn&edition=full","pubTime":"2026-08-28 17:51","pubTimestamp":1787910712,"startTime":"0","endTime":"0","summary":"证券之星消息，近日东富龙披露，截至2026年6月30日公司股东户数为2.93万户，较3月31日减少851.0户，减幅为2.82%。在医疗器械行业个股中，东富龙股东户数高于行业平均水平，截至6月30日，医疗器械行业平均股东户数为2.12万户。从股价来看，2026年3月31日至2026年6月30日，东富龙区间跌幅为22.02%，在此期间股东户数减少851.0户，减幅为2.82%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800041438.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300171"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662087208","title":"图解东富龙中报：第二季度单季净利润同比增长210.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662087208","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662087208?lang=zh_cn&edition=full","pubTime":"2026-08-28 02:46","pubTimestamp":1787856368,"startTime":"0","endTime":"0","summary":"证券之星消息，东富龙2026年中报显示，上半年度公司主营收入25.35亿元，同比上升4.37%；归母净利润1.08亿元，同比上升134.49%；扣非净利润9444.35万元，同比上升270.73%；其中2026年第二季度，公司单季度主营收入14.26亿元，同比上升10.45%；单季度归母净利润8016.37万元，同比上升210.87%；单季度扣非净利润7761.77万元，同比上升827.98%；负债率39.53%，投资收益684.05万元，财务费用3228.28万元，毛利率32.17%。财报数据概要请见下图:本文数据来源于东富龙2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800006047.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300171"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662343085","title":"东富龙（300171）披露2026年半年度报告，8月27日股价上涨0.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662343085","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662343085?lang=zh_cn&edition=full","pubTime":"2026-08-27 22:07","pubTimestamp":1787839662,"startTime":"0","endTime":"0","summary":"截至2026年8月27日收盘，东富龙报收于14.99元，较前一交易日上涨0.33%，最新总市值为114.8亿元。该股当日开盘14.78元，最高15.23元，最低14.65元，成交额达3.45亿元，换手率为4.1%。近日，东富龙披露2026年半年度报告。报告显示，本期营业收入2,534,573,184.09元，同比增长4.37%；归属于上市公司股东的净利润107,678,132.77元，同比增长134.49%；扣除非经常性损益后的净利润94,443,548.36元，同比增长270.73%。经营活动产生的现金流量净额91,104,156.17元，同比下降67.03%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700054631.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300171","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660402256","title":"8月20日东富龙涨11.95%，金信深圳成长混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2660402256","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660402256?lang=zh_cn&edition=full","pubTime":"2026-08-20 16:42","pubTimestamp":1787215327,"startTime":"0","endTime":"0","summary":"证券之星消息，8月20日东富龙涨11.95%创60日新高，收盘报14.9元，换手率9.58%，成交量53.88万手，成交额8.05亿元。重仓东富龙的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为金信基金的金信深圳成长混合A。金信深圳成长混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000028983.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300171","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659690420","title":"东富龙新注册《全自动微球滴珠机控制系统V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2659690420","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659690420?lang=zh_cn&edition=full","pubTime":"2026-08-13 02:12","pubTimestamp":1786558338,"startTime":"0","endTime":"0","summary":"证券之星消息，近日东富龙（300171）新注册了《全自动微球滴珠机控制系统V1.0》项目的软件著作权。今年以来东富龙新注册软件著作权4个，较去年同期增加了100%。结合公司2025年年报财务数据，2025年公司在研发方面投入了3.38亿元，同比减2.49%。通过天眼查大数据分析，东富龙科技集团股份有限公司共对外投资了29家企业，参与招投标项目826次；财产线索方面有商标信息70条，专利信息1800条，著作权信息75条；此外企业还拥有行政许可151个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300001475.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300171","159180","BK0251"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1791460947945,"stockEarnings":[{"period":"1week","weight":0.0067},{"period":"1month","weight":0.1014},{"period":"3month","weight":0.4171},{"period":"6month","weight":0.1648},{"period":"1year","weight":0.1664},{"period":"ytd","weight":0.0587}],"compareEarnings":[{"period":"1week","weight":-0.024},{"period":"1month","weight":-0.0362},{"period":"3month","weight":-0.0463},{"period":"6month","weight":-0.0098},{"period":"1year","weight":-0.0105},{"period":"ytd","weight":-0.0319}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"东富龙科技集团股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"29299人(较上一季度减少2.82%)","perCapita":"19404股","listingDate":"2011-02-01","address":"上海市闵行区都会路1509号4幢","registeredCapital":"76582万元","survey":"　　东富龙科技集团股份有限公司的主营业务是为全球制药企业提供制药工艺、核心装备、系统工程整体解决方案。公司的主要产品是制剂装备、生物工艺装备及耗材、制药工程、食品工程及装备。","listedPrice":86},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"东富龙(300171)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供东富龙(300171)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"东富龙,300171,东富龙股票,东富龙股票老虎,东富龙股票老虎国际,东富龙行情,东富龙股票行情,东富龙股价,东富龙股市,东富龙股票价格,东富龙股票交易,东富龙股票购买,东富龙股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"东富龙(300171)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供东富龙(300171)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}